CHA Submits Energy and Commerce Committee Statement on Oversight of the 340B Drug Pricing Program

Children's Hospital Association urges the committee to work with provider stakeholders to enhance the effectiveness and integrity of the program for children's health.
DOWNLOAD

The House Energy and Commerce Subcommittee on Oversight and Investigations held a hearing titled, “Oversight of the 340B Drug Pricing Program.” The discussion focused on the 340B drug pricing program’s impact on patients, the health care system, and potential reforms.

Children's Hospital Association submitted a statement expressing our strong support for the program as well as our concerns about the 340B ACCESS Act and urged the committee to work with provider stakeholders to further enhance the effectiveness and integrity of the program. 

Hand

Contact Us

For more information, connect with us.

(202) 753-5337

Related Content

How a Health Care Supply Chain Officer Supports Patient Care

Discover insights from a longtime children’s hospital supply chain leader on supporting patient care, community needs, and the health care supply chain.

Sep. 16, 2025

The Transforming Power of Sickle Cell Gene Therapy (and Why Access Is Important)

A revolutionary therapy takes some children’s lives to new heights. Others are left out.

Sep. 12, 2025

Ensuring Access to Critical Medicines for Children

Discover how Angels for Change partners with manufacturers to prevent shortages and keep lifesaving pediatric drugs available.

Aug. 26, 2025